[Our experience with Daonil. A new oral hypoglycemic agent].
作者信息
Rodriguez-Miñon J L, Arrieta F, Herrera J L
出版信息
Diabete. 1970 Jul-Sep;18(3):164-5.
PMID:5472233
Abstract
摘要
相似文献
1
[Our experience with Daonil. A new oral hypoglycemic agent].
Diabete. 1970 Jul-Sep;18(3):164-5.
2
[Glybenclamide and its place among sulfanylureas in the treatment of diabetes mellitus].
Rev Clin Esp. 1970 May 31;117(4):375-86.
3
[Progress in diabetes therapy using glibenclamide and phenformin. Report from the years 1967-1970 on 323 patients].
Dtsch Med Wochenschr. 1971 Apr 23;96(17):728-33. doi: 10.1055/s-0028-1108320.
4
Glibenclamide in the management of diabetes mellitus. I.
J Ir Med Assoc. 1971 Apr 8;64(409):197-9.
5
[Preliminary results with a new oral antidiabetic drug of the sulfanylurea series: glibenclamide or HB 419].
Minerva Med. 1970 Dec 5;61(97):5525-42.
6
[The development of sulfonylurea late resistance].
Med Klin. 1970 Feb 13;65(7):306-9.
7
[Oral differential therapy of diabetes mellitus].[糖尿病的口腔差异治疗]
Dtsch Med Wochenschr. 1970 Aug 28;95(35):1795-6.
8
Clinical experience with glybenclamide in 100 non-ketotic diabetics.
Indian J Med Res. 1971 Feb;59(2):251-8.
9
[Personal experience on the use of glybenclamide (a new oral hypoglycemic agent)].[格列本脲（一种新型口服降糖药）的使用个人经验]
Rev Clin Esp. 1970 May 31;117(4):371-4.
10
[Oral treatment of diabetes mellitus with the new sulfonylurea tolazamide].用新型磺脲类药物甲苯磺丁脲口服治疗糖尿病
Arzneimittelforschung. 1969 Jul;19(7):1128-30.
Zotero 插件